Anavex Life Sciences
AVXL
#9984
Rank
NZ$0.13 B
Marketcap
NZ$1.49
Share price
-12.42%
Change (1 day)
-76.43%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -NZ$22.19 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$72.7 Million, an increase over its 2024 earnings that were of -NZ$93.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$22.19 Million-69.48%
2025 -NZ$72.7 Million-22.43%
2024 -NZ$93.72 Million14.77%
2023 -NZ$81.67 Million-17.49%
2022 -NZ$98.97 Million22.96%
2021 -NZ$80.49 Million35.36%
2020 -NZ$59.47 Million12.65%
2019 -NZ$52.79 Million29.09%
2018 -NZ$40.89 Million36.33%
2017 -NZ$30 Million17.11%
2016 -NZ$25.62 Million20.91%
2015 -NZ$21.19 Million-6.29%
2014 -NZ$22.61 Million337.28%
2013 -NZ$5.17 Million
2008 -NZ$9.56 Million106.01%
2007 -NZ$4.65 Million8848.98%
2006 -NZ$0.06 Million-79.99%
2005 -NZ$0.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$0.11 B-570.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$0.20 B-956.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$15.22 Million-35.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.65 Billion 2,638.61%๐Ÿ‡บ๐Ÿ‡ธ USA